[HTML][HTML] Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus

A Grupper, L Rabinowich, D Schwartz… - American Journal of …, 2021 - Elsevier
COVID-19 is associated with increased morbidity and mortality in transplant recipients.
There are no efficacy data available regarding these patients with any of the available SARS …

Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus

A Grupper, L Rabinowich… - … : official journal of …, 2021 - pubmed.ncbi.nlm.nih.gov
COVID-19 is associated with increased morbidity and mortality in transplant recipients.
There are no efficacy data available regarding these patients with any of the available SARS …

[HTML][HTML] Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus

A Grupper, L Rabinowich, D Schwartz… - American Journal of …, 2021 - ncbi.nlm.nih.gov
COVID-19 is associated with increased morbidity and mortality in transplant recipients.
There are no efficacy data available regarding these patients with any of the available SARS …

Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus.

A Grupper, L Rabinowich, D Schwartz… - American Journal of …, 2021 - europepmc.org
COVID‐19 is associated with increased morbidity and mortality in transplant recipients.
There are no efficacy data available regarding these patients with any of the available SARS …

Reduced humoral response to mRNA SARS‐CoV‐2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus

A Grupper, L Rabinowich, D Schwartz… - American Journal of …, 2021 - Wiley Online Library
COVID‐19 is associated with increased morbidity and mortality in transplant recipients.
There are no efficacy data available regarding these patients with any of the available SARS …

[引用][C] Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus

A Grupper, L Rabinowich, D Schwartz… - American Journal of …, 2021 - cir.nii.ac.jp
Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant
recipients without prior exposure to the virus | CiNii Research CiNii 国立情報学研究所 学術情報 …

Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus.

A Grupper, L Rabinowich, D Schwartz, IF Schwartz… - 2021 - cabidigitallibrary.org
COVID-19 is associated with increased morbidity and mortality in transplant recipients.
There are no efficacy data available regarding these patients with any of the available SARS …

Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus

A Grupper, L Rabinowich, D Schwartz… - American Journal of …, 2021 - amjtransplant.org
COVID-19 is associated with increased morbidity and mortality in transplant recipients.
There are no efficacy data available regarding these patients with any of the available SARS …

Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus: Not alarming, but should be …

A Grupper, H Katchman - American Journal of Transplantation, 2021 - ncbi.nlm.nih.gov
We greatly appreciate the time taken by S. Mossad1 to point out issues that are crucial in the
field of transplant recipients' vaccination. The SARS-CoV-2 vaccines have been widely …

Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus: Not alarming, but should be …

A Grupper, H Katchman - American Journal of Transplantation, 2021 - amjtransplant.org
We greatly appreciate the time taken by S. Mossad1 to point out issues that are crucial in the
field of transplant recipients' vaccination. The SARS-CoV-2 vaccines have been widely …